A recent study suggests that individuals who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight far faster than those who halt conventional lifestyle programs.
Findings released in a prominent health publication demonstrates that while overweight people can lose substantial amounts of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month after stopping.
"Users purchasing such medications need to be cognizant of the risk of fast weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.
This pace of regain suggests a return to pre-treatment weight within about one and a half years.
Analyzing Treatments
The study, which looked at 37 of studies involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with other pills.
Researchers point out that individuals who shed pounds through dieting typically see a slower weight regain—approximately 100 grams monthly—after stopping.
Explaining the Fast Regain
Experts believe the mechanism of the injections accounts for the accelerated rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making binge eating far more likely."
A Chronic Disease?
Health authorities advise the injections for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
Professionals contend that, given the significant potential of relapse, the treatment should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who say that the findings "underscore the long-term character of excess weight," akin to managing conditions like hypertension.
User Testimonies
People who have discontinued the medication report a intense resurgence of cravings.
"I experienced a switch activating and I was suddenly ravenous," described one woman.
The struggle is compounded if individuals have not adopted permanent dietary or behavioural changes during therapy.
Widespread Interest
Figures indicate that a significant number of people in the UK have used these injections in the past year, with interest remaining high.
- Adoption is more common among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians stress that while the jabs are effective agents for shedding pounds, they are not a permanent cure and maintained weight loss hinges on ongoing lifestyle changes.
